# Intergenerational Transmission of Metabolic Changes in Oocytes From Aged Mice

**Authors:** Hafsa Gulzar, Richard Musson, Simona Bisogno, Lulu Alluhaibi, Alexey Maximenko, Ewelina Bik, Małgorzata Barańska, Joanna Depciuch, Grażyna E. Ptak

PMC · DOI: 10.1111/acel.70426 · Aging Cell · 2026-02-26

## TL;DR

This study shows that aging in mice mothers leads to metabolic changes in their eggs, which can affect future generations' health.

## Contribution

The study reveals transgenerational metabolic changes in oocytes from aged mice, including lipid and retinoid alterations.

## Key findings

- Oocytes from aged mice show increased lipid droplets and oxidative changes.
- Metabolic changes persist in offspring organs and trigger antioxidant responses.
- Altered metabolism is transmitted to the third generation of mouse oocytes.

## Abstract

The increase in maternal age of pregnancies is a global phenomenon that may have wide‐ranging implications for the future health of the next generations. We have previously shown that oocytes from females at advanced maternal age (AMA F0) accumulate intracytoplasmic lipid droplets (LDs), and that oxidative changes to lipids in oocytes from AMA F0 mice are maintained in preimplantation embryos. Here we explore whether oxidative changes are transmitted to the foetus, and what effects this has on neonatal and adult organ development, and the transgenerational inheritance of these changes. First, we show increased antioxidants in lipid‐rich organs (liver and brain) of AMA‐derived prenatal mice (AMA F1), indirectly showing increased oxidative stress. Then, we provide evidence of metabolic reprogramming in adult offspring of AMA and the accumulation of lipids in AMA‐derived third generation (AMA F3) mouse oocytes. In particular, we demonstrate the accumulation of retinoids and other mediators of oxidative phosphorylation (OXPHOS) in AMA F0 and AMA F3 oocytes. Altogether, an altered oxidative metabolism of AMA F0 oocytes may constitute a base of oxidative changes in the organs of offspring and of their transgenerational inheritance to AMA F3 oocytes. Our findings indicate a remodelling of lipid homeostasis in oocytes of female mice derived from AMA great‐grandmothers and highlight the need to take a closer look at the inheritance of metabolic changes from mothers of advanced age into their offspring.

This study shows that oxidative changes in oocytes from aged female mice lead to lipid droplet accumulation and altered energy and retinoid metabolism. These changes persist in embryonic organs, triggering antioxidant responses in lipid‐rich tissues. Remarkably, altered profiles are transmitted across generations, reaching third generation, suggesting that maternal aging remodels oocyte metabolism with transgenerational effects.

## Linked entities

- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Fasn (fatty acid synthase) [NCBI Gene 14104] {aka A630082H08Rik, FAS}, Srebf1 (sterol regulatory element binding transcription factor 1) [NCBI Gene 20787] {aka ADD1, SREBP1, bHLHd1}, Ppara (peroxisome proliferator activated receptor alpha) [NCBI Gene 19013] {aka 4933429D07Rik, Nr1c1, PPAR-alpha, PPARalpha, Ppar}, Pparg (peroxisome proliferator activated receptor gamma) [NCBI Gene 19016] {aka Nr1c3, PPAR-gamma, PPAR-gamma2, PPARgamma, PPARgamma2}
- **Diseases:** impaired liver performance (MESH:D017093), hepatic cellular damage (MESH:D056486), AMA (MESH:D000079262), dislocation (MESH:D004204), oocyte defects (OMIM:615774), chronic (MESH:D002908), cognitive decline (MESH:D003072), OS (MESH:D000079225), Decreased bodyweight (MESH:D009123), defects in the brain (MESH:D001927), placental dysfunction (MESH:D010922), cardiovascular diseases (MESH:D002318), DOHaD (OMIM:603663), insulin resistance (MESH:D007333), HCA (MESH:D003027), obese (MESH:D009765), weight gain (MESH:D015430), steatohepatitis (MESH:D005234), PC (MESH:C535298), Metabolic dysfunctions (MESH:D008659), metabolic dysregulation (MESH:D021081), cervical dislocation (MESH:D002575), liver diseases (MESH:D008107), inflammation (MESH:D007249), neurodegenerative disease (MESH:D019636), mitochondrial dysfunction (MESH:D028361), bodyweight alterations (MESH:D004408), cancer (MESH:D009369), diabetes (MESH:D003920), NAFLD (MESH:D065626)
- **Chemicals:** GSH (MESH:D005978), ATP (MESH:D000255), polypropylene (MESH:D011126), Lipid (MESH:D008055), NAD+ (MESH:D009243), PBS (MESH:D007854), sphingolipids (MESH:D013107), ROS (MESH:D017382), Sph (MESH:D013109), PE (MESH:C483858), Cer (-), alpha-ketoglutarate (MESH:D007656), PUFA (MESH:D005231), retinoic acid (MESH:D014212), sulfatides (MESH:D013433), PC (MESH:D010713), fatty acid (MESH:D005227), PS (MESH:D010718), GSSG (MESH:D019803), carotenoids (MESH:D002338), phospholipids (MESH:D010743), Vitamin A (MESH:D014801), S-adenosylmethionine (MESH:D012436), Retinoid (MESH:D012176), CaF2 (MESH:D002124), anandamide (MESH:C078814), retinal (MESH:D012172), ceramides (MESH:D002518), cholesterol (MESH:D002784), SP8 (MESH:C007472), PI (MESH:D010716), sugar (MESH:D000073893)
- **Species:** Drosophila melanogaster (fruit fly, species) [taxon 7227], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Felis catus (cat, species) [taxon 9685], C. elegans [taxon 328850], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), /6 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_5985)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938507/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12938507/full.md

## References

109 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938507/full.md

---
Source: https://tomesphere.com/paper/PMC12938507